Anti-TNF, infliximab, and adalimumab can be effective in eosinophilic bowel disease
- Dan Turner*
- , Victorien M. Wolters
- , Richard K. Russell
- , Valentina Shakhnovich
- , Aleixo M. Muise
- , Oren Ledder
- , Bo Ngan
- , Craig Friesen
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
32
Scopus
citations